Parents were more likely to seek a second opinion when they were not optimistic about their child’s life expectancy, felt pressured by the PC to terminate the pregnancy, were told that their child’s death was “”somewhat”" or “”very”" likely, or were told the child’s CHD was “”rare”" (all p < 0.01). Two thirds (66 %) of the respondents were told that their child’s condition was “”rare.”" The majority of these (77 %) reported that the term was used by the PC. “”Rare”" was interpreted as “”occurring STI571 price in less than a million births”" by 25 %, and as “”few or no other people alive
with this defect”" by 27 %. Parental interpretation of “”rare”" was unrelated to their levels of education. As reported by the respondents, 13 % felt pressured to terminate the pregnancy by the PC. Those with hypoplastic left heart
syndrome were more likely to report feeling pressure to terminate the pregnancy by the PC (21 vs 9 %; p < 0.001) or the perinatologist (23 vs 14 %; p = 0.026). The approach to counseling and the demeanor of the PC have important implications click here for parents’ perceptions of their child’s chance of survival. The information given at diagnosis, the manner in which it is presented, and the parents’ understanding and interpretation of that information are critical factors in shaping parents’ perceptions and management decisions.”
“Glioblastoma is one of the most malignant brain tumors. Current treatments for glioblastoma usually make poor responses, and novel treatment strategies are extremely imperative. Cytochalasin E was reported to inhibit angiogenesis and tumor growth in some studies, but its effects on gliomas are still unknown. In this study, we found cytochalasin E inhibits U87 human glioblastoma cell growth in a very low concentration range of 10(-8) to 10(-6) M in a time and concentration dependent manner, and the IC50 were 1.17 +/- 032 x 10(-7) M for 48 h treatment, 6.65 +/- 1.12 x 10(-8) M for 72 h and 3.78 +/- 130 x 10(-8) M for 96 GSI-IX nmr h.
We also found cytochalasin E induces cell-cycle G2/M phase arrest (72 h-treatment of 10(-6) M cytochalasin E caused 56.2 +/- 6.1% cells arrest in G2/M phase) and cell apoptosis (96 h-treatment of 10(-6) M cytochalasin E induced 24.1 +/- 4.2% cells apoptosis). Thus, cytochalasin E is proposed as a potential agent for glioblastoma chemotherapy.”
“Turner syndrome (TS), a genetic abnormality affecting 1 in 2,500 people, is commonly associated with congenital heart disease (CHD). However, the surgical outcomes for TS patients have not been well described. This study reviewed the spectrum of CHD in TS at the authors’ center. The authors report outcomes after coarctation of the aorta (CoA) repair or staged palliation of hypoplastic left heart syndrome (HLHS) and then compare the surgical outcomes with those of non-TS patients undergoing like repair.